Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Jul;54(7):671-6.
doi: 10.1007/s00262-004-0639-0. Epub 2004 Dec 30.

Apoptosis and production of TNF-alpha by tumor-associated inflammatory cells in histological grade III breast cancer

Affiliations

Apoptosis and production of TNF-alpha by tumor-associated inflammatory cells in histological grade III breast cancer

Farias Rogério Estevam et al. Cancer Immunol Immunother. 2005 Jul.

Abstract

Tumor necrosis factor alpha (TNF-alpha) is a cytokine that acts as an important mediator of the apoptotic process that also demonstrates selective citotoxicity against malignant breast tumor cells. In the present study, the presence of apoptotic tumor cells and the synthesis of TNF-alpha by inflammatory cells were investigated in tissue samples from grade III invasive breast cancer with long-term follow-up. In situ detection of tumor apoptotic cells was investigated by direct immuno-peroxidase of digoxigenin-labeled genomic DNA. The production of TNF-alpha and tumor cell proliferation were investigated by immunohistochemical procedures. Our data demonstrated that patients with a clinical history of cancer recurrence and metastasis presented a lower number of cancerous apoptotic cells, higher tumor proliferation rates, and lower TNF-alpha expression rates by inflammatory cells than what is observed among patients diagnosed with the same histopathological breast cancer type but in the absence of tumor recurrence and metastasis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Histopathological analyses and proliferative index. a Poorly differentiated ductal carcinoma. Classified as grade III. Arrows: note several tumor-associated mononuclear inflammatory cells (hematoxilin and eosin 200× magnification). Tumoral cells area delineated by a blue line. b Proliferative index investigated by Ki67 antibody (grupo II): many Ki 67 positive cells in grade III ductal carcinoma (400× magnification). Arrows: indicates a Ki 67 positive cell. In set: negative control of the immunohistochemical procedure(400× magnification). c Number of Ki67 positive cells. Tumoral cells observed in ten microscopic fields. At least 500 cells, with 400× magnification were counted. Results expressed in %, (Mean+/−SD), N=25, of total tumor cells. Not statistically significant differences (p>0.05) were noted in Group I when compared to Group II
Fig. 2
Fig. 2
Positive staining of TNFα in tumor surrounding inflammatory cells in grade III ductal carcinoma. Arrows: indicate positive cells. Tumoral cells area delineated by a blue line. a Group I: patients without metastasis or recurrence (400× magnification). In set: negative control of the immunohistochemical procedure(200× magnification). b Group II: patients with recurrence and metastasis (400× magnification). c Number of TNFα positive cells. Inflammatory cells observed in ten microscopic fields. At least 1,000 cells, with 400× magnification were counted. Results expressed in %, (Mean+/−SD), N=25, of total tumor-associated inflammatory cells.Statistically significant differences (p<0,05) were noted in Group I when compared to Group II
Fig. 3
Fig. 3
Apoptotic tumor cells in grade III ductal carcinoma detected by TUNEL method. Arrows: indicate apoptotic cells. a Group I: patients without metastasis or recurrence (400× magnification). In set: negative control of the immunohistochemical procedure(100× magnification). b Group II: patients with recurrence and metastasis (400× magnification). c) Number of apoptotic cells. Tumoral cells observed in ten microscopic fields. At least 500 cells, with 400× magnification were counted. Results expressed in %, (Mean+/−SD), N=25, of total tumor cells. Statistically significant differences (p<0.05) were noted in Group I when compared to Group II

References

    1. Ardizzoia A, Lissoni P, Brivio F, Tisi E, Perego MS, Grassi MG, Pittalis S, Crispino S, Barni S, Tancini G. Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease. J Biol Reg Hom Agentes. 1992;6:103–107. - PubMed
    1. Basu A, Mohanty S, Sun B. Differential sensitivity of breast cells to tumor necrosis factor-α: involvement of protein kinase C. Bioch Biophy Res Commu. 2001;280:883–891. doi: 10.1006/bbrc.2000.4209. - DOI - PubMed
    1. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 were followed for 15 years. Br J Cancer. 1957;11:359–377. - PMC - PubMed
    1. Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med. 2002;64:604–611. - PubMed
    1. Caras I, Grigorescu A, Stavaru C, Radu DL, Mogos I, Szegli G, Salageanu A (2004) Evidence of immune defects in breast and lung cancer patients. Cancer Immunol Immunother. Epub - PMC - PubMed

Publication types

MeSH terms

Substances